SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Tuesday reported a loss of $85.7 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 14 cents.

The immunotherapy company posted revenue of $6.1 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IBRX at https://www.zacks.com/ap/IBRX